Non-nucleoside reverse transcriptase inhibitors

Details Non-nucleoside reverse transcriptase inhibitors Non-nucleoside reverse transcriptase inhibitors

2011-08-16

2011-08-16

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S275000, C544S296000, C544S321000, C544S323000, C544S324000

Reexamination Certificate

active

07998969

ABSTRACT:
The present invention provides for compounds useful for treating an HIV infection, or preventing an HIV infection, or treating AIDS or ARC. The compounds of the invention are of formula I wherein R1, R2, R3, R4, R5a, R5b, R6a, R6band X are as herein defined. Also disclosed in the present invention are methods of treating an HIV infection with compounds defined herein and pharmaceutical compositions containing said compounds.

REFERENCES:
patent: WO 00/03998 (2000-01-01), None
patent: WO 03/016306 (2003-02-01), None
patent: WO 2006/035067 (2006-04-01), None
patent: WO 2006/035067 (2006-04-01), None
patent: WO 2006/035068 (2006-04-01), None
patent: WO 2006/035068 (2006-04-01), None
patent: WO 2006/035369 (2006-04-01), None
patent: WO 2006/035369 (2006-04-01), None
patent: WO 2006/045828 (2006-05-01), None
patent: WO 2006/087387 (2006-08-01), None
patent: WO 2006/094930 (2006-09-01), None
Miles, Medline Abstract (Community Pract, vol. 78, Issue 8, pp. 292-294) Aug. 2005.
van Heeswijk et al., PubMed Abstract (Antivir Ther. 6(4):201-29) Dec. 2001.
Marcus et al., PubMed Abstract (Intervirology 45(4-6):260-6) 2002.
Brugel, T.A., et. al. “Development ofN-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1,”Bioorganic&Medicinal Chemistry Letters(2006) vol. 16, pp. 3510-3513.
Das, K., et. al. “Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside reverse Transcriptase Inhibitors that are Highly Potent and Effective Against Wild-type and Drug—Resistant HIV-1 Variants,”J. Med. Chem.(2004) vol. 47, pp. 2550-2560.
Guillemont, J., et. al. “Synthesis of Novel Diarylpyrimidine Analogues and Their Antiviral Activity against Human Immunodeficiency Virus Type 1,”J. Med. Chem.(2005) vol. 48, pp. 2072-2079.
Janssen, P.A., et. al. “In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine),”J. Med. Chem. (2005) vol. 48, pp. 1901-1909.

Affiliated with

Also associated with

Rating

Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2746661